Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement

Pinak B. Shah; Frederick G.P. Welt; Ehtisham Mahmud; Alistair Phillips; Neal S. Kleiman; Michael N. Young; Matthew Sherwood; Wayne Batchelor; Dee Dee Wang; Laura Davidson; Janet Wyman; Sabeeda Kadavath; Molly Szerlip; James Hermiller; David Fullerton; Saif Anwaruddin

doi:10.1002/ccd.28910

Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement

Pinak B. Shah^*, Frederick G.P. Welt, Ehtisham Mahmud, Alistair Phillips, Neal S. Kleiman, Michael N. Young, Matthew Sherwood, Wayne Batchelor, Dee Dee Wang, Laura Davidson, Janet Wyman, Sabeeda Kadavath, Molly Szerlip, James Hermiller, David Fullerton, Saif Anwaruddin

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment, as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.

Original language	English (US)
Pages (from-to)	659-663
Number of pages	5
Journal	Catheterization and Cardiovascular Interventions
Volume	96
Issue number	3
DOIs	https://doi.org/10.1002/ccd.28910
State	Published - Sep 1 2020

Funding

Dr. Shah is a proctor for Edwards Lifesciences; and has received educational grants from Edwards Lifesciences, Medtronic, and Abbott. Dr. Welt is a site principal investigator for a multicenter trial supported by Medtronic; and is on the advisory board for Medtronic. Dr. Mahmud is a consultant for Abiomed, Medtronic, and Boston Scientific; and chairs multiple data and safety monitoring boards. Dr. Kleiman has received research grants from Medtronic; and serves on steering committees for the PROTECTED TAVR study, sponsored by Boston Scientific, and the PORTICO NG study, sponsored by Abbott. Dr. Sherwood is a consultant for Medtronic. Dr. Batchelor is a consultant for V Wave Medical and Abbott; and is on the Speakers Bureau for Boston Scientific, Medtronic, and Abbott. Dr. Wang is a consultant for Edwards Lifesciences and Boston Scientific. Dr. Wyman is a consultant for Edwards Lifesciences and Boston Scientific. Dr. Szerlip is a consultant and proctor for Edwards Lifesciences; is a consultant for Medtronic; and is a consultant and member of the Speakers Bureau for Boston Scientific. Dr. Hermiller is a consultant for Medtronic, Edwards Lifesciences, and Abbott. Dr. Anwaruddin is on the advisory board for Medtronic; is a consultant and proctor for Medtronic and Edwards Lifesciences; is on the steering committee for Boston Scientific; and is a proctor for V Wave Medical.

Keywords

COVID-19
MitraClip
TAVR
structural heart disease

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ccd.28910

Cite this

Shah, P. B., Welt, F. G. P., Mahmud, E., Phillips, A., Kleiman, N. S., Young, M. N., Sherwood, M., Batchelor, W., Wang, D. D., Davidson, L., Wyman, J., Kadavath, S., Szerlip, M., Hermiller, J., Fullerton, D., & Anwaruddin, S. (2020). Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement. Catheterization and Cardiovascular Interventions, 96(3), 659-663. https://doi.org/10.1002/ccd.28910

@article{782b9de2b37d4beaba60fa9340a008a6,

title = "Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement",

abstract = "The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment, as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.",

keywords = "COVID-19, MitraClip, TAVR, structural heart disease",

author = "Shah, {Pinak B.} and Welt, {Frederick G.P.} and Ehtisham Mahmud and Alistair Phillips and Kleiman, {Neal S.} and Young, {Michael N.} and Matthew Sherwood and Wayne Batchelor and Wang, {Dee Dee} and Laura Davidson and Janet Wyman and Sabeeda Kadavath and Molly Szerlip and James Hermiller and David Fullerton and Saif Anwaruddin",

note = "Publisher Copyright: {\textcopyright} 2020 by the American College of Cardiology Foundation and Wiley Periodicals, Inc.",

year = "2020",

month = sep,

day = "1",

doi = "10.1002/ccd.28910",

language = "English (US)",

volume = "96",

pages = "659--663",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

Shah, PB, Welt, FGP, Mahmud, E, Phillips, A, Kleiman, NS, Young, MN, Sherwood, M, Batchelor, W, Wang, DD, Davidson, L, Wyman, J, Kadavath, S, Szerlip, M, Hermiller, J, Fullerton, D & Anwaruddin, S 2020, 'Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement', Catheterization and Cardiovascular Interventions, vol. 96, no. 3, pp. 659-663. https://doi.org/10.1002/ccd.28910

Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement. / Shah, Pinak B.; Welt, Frederick G.P.; Mahmud, Ehtisham et al.
In: Catheterization and Cardiovascular Interventions, Vol. 96, No. 3, 01.09.2020, p. 659-663.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic

T2 - An ACC/SCAI position statement

AU - Shah, Pinak B.

AU - Welt, Frederick G.P.

AU - Mahmud, Ehtisham

AU - Phillips, Alistair

AU - Kleiman, Neal S.

AU - Young, Michael N.

AU - Sherwood, Matthew

AU - Batchelor, Wayne

AU - Wang, Dee Dee

AU - Davidson, Laura

AU - Wyman, Janet

AU - Kadavath, Sabeeda

AU - Szerlip, Molly

AU - Hermiller, James

AU - Fullerton, David

AU - Anwaruddin, Saif

PY - 2020/9/1

Y1 - 2020/9/1

N2 - The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment, as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.

AB - The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment, as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.

KW - COVID-19

KW - MitraClip

KW - TAVR

KW - structural heart disease

UR - http://www.scopus.com/inward/record.url?scp=85085521334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085521334&partnerID=8YFLogxK

U2 - 10.1002/ccd.28910

DO - 10.1002/ccd.28910

M3 - Article

C2 - 32251546

AN - SCOPUS:85085521334

SN - 1522-1946

VL - 96

SP - 659

EP - 663

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - 3

ER -

Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this